Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

1(33.3%)

Phase 2

1(33.3%)

Phase 3

1(33.3%)

3Total

Phase 4(1)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06236698Completed

The Diagnostic Performance of 24-hour Urinary Aldosterone for Primary Aldosteronism

Role: lead

NCT05068895Unknown

Assessment of Metabolic Profiles of Lower Extremity Arterial Disease in Patiens Withe Type 2 Diabetes

Role: lead

NCT01408446Phase 2Completed

Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients

Role: lead

NCT02050984Unknown

Effect of Bariatric Surgery on Blood Pressure

Role: lead

NCT01974037Phase 4Completed

Capsaicin on Salty Gustatory Cortices

Role: lead

NCT01982669Completed

Spicy Diet on Salty Taste and Salt Intake

Role: lead

NCT01816698Phase 3Completed

Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive

Role: lead

All 7 trials loaded